Close Menu

NEW YORK (360Dx) — Quidel's immunoassay platform and assay for respiratory syncytial virus has been granted 510(k) approval by the US Food and Drug Administration.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.